<DOC>
	<DOCNO>NCT01679561</DOCNO>
	<brief_summary>Both organ-specific systemic autoimmunity associate increase prevalence recurrent miscarriage reproductive failure , render role maternal immunological system fertility key concept . It believe central theme maternal cytokine profile , particularly T-helper ( Th ) cell . Immune modulate therapy therefore moot potential therapeutic strategy . Recent report high pregnancy rate achievable woman RIF add fuel debate regard effectiveness intralipids modulate immune system .</brief_summary>
	<brief_title>Intralipid Therapy Recurrent Implantation Failure Recurrent Miscarriages : Is Hope Myth ? A Randomized Clinical Trial</brief_title>
	<detailed_description>The investigator would like assess intralipids therapy effective treatment woman undergo repeat failed assist reproduction cycle recurrent miscarriages traditional method randomise clinical trial ( RCT ) .</detailed_description>
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<mesh_term>Soybean oil , phospholipid emulsion</mesh_term>
	<criteria>1 . Recurrent unexplained fail IVF , ICSI . 2 . Recurrent unexplained miscarriage . 3 . High level peripheral uterine NK . 1 . Age forty year old . 2 . Antiphospholipid syndrome ( lupus anticoagulant and/or anticardiolipin antibody [ IgG IgM ] ) ; recognise thrombophilic condition ( test accord usual clinic practice ) . 3 . Intrauterine abnormality ( assess ultrasound , hysterosonography , hysterosalpingogram , hysteroscopy ) . 4 . Fibroids distort uterine cavity . 5 . Abnormal parental karyotype . 6 . Other identifiable cause recurrent miscarriage ( test initiate clinically indicate ) e.g. , diabetes , thyroid disease systemic lupus erythematosus ( SLE ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>implantation failure</keyword>
	<keyword>recurrent abortion</keyword>
	<keyword>intralipid</keyword>
</DOC>